1. Home
  2. ADNT vs ATRC Comparison

ADNT vs ATRC Comparison

Compare ADNT & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adient plc

ADNT

Adient plc

HOLD

Current Price

$18.89

Market Cap

1.5B

ML Signal

HOLD

Logo AtriCure Inc.

ATRC

AtriCure Inc.

HOLD

Current Price

$39.50

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADNT
ATRC
Founded
2016
2000
Country
Ireland
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.6B
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
ADNT
ATRC
Price
$18.89
$39.50
Analyst Decision
Hold
Strong Buy
Analyst Count
9
9
Target Price
$22.11
$52.00
AVG Volume (30 Days)
1.3M
530.9K
Earning Date
11-05-2025
10-29-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$14,535,000,000.00
$518,304,999.00
Revenue This Year
$0.98
$16.90
Revenue Next Year
$2.62
$12.29
P/E Ratio
N/A
N/A
Revenue Growth
N/A
15.80
52 Week Low
$10.04
$28.29
52 Week High
$26.16
$43.11

Technical Indicators

Market Signals
Indicator
ADNT
ATRC
Relative Strength Index (RSI) 39.42 65.81
Support Level $18.76 $34.88
Resistance Level $19.76 $38.90
Average True Range (ATR) 0.79 1.84
MACD 0.11 0.46
Stochastic Oscillator 39.49 98.37

Price Performance

Historical Comparison
ADNT
ATRC

About ADNT Adient plc

Adient began trading Oct. 31, 2016, when Johnson Controls spun off its automotive experience segment. Adient is a leading seating supplier to the industry with about a midteens share of the global market including unconsolidated joint venture business. Its share in China is around 20%, down from about 45%, following the sale of its main joint venture there at the end of fiscal 2021. Unconsolidated revenue from joint ventures was about $3.5 billion in fiscal 2025 and consolidated China revenue was $1.3 billion. The company is headquartered in Ireland but has corporate offices in the Detroit area. Fiscal 2025 (Sept. 30 year-end) consolidated revenue, which excludes joint venture sales, was $14.5 billion.

About ATRC AtriCure Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

Share on Social Networks: